Development of a program for kidney transplants using organs donated from donors awaiting cardiac arrest (type III Maastricht)

Nefrologia

Volumn 32, Issue 6, 2012, Pages 754-759

  Portolés Pérez, José ^a   Rubio Muñoz, Juan J ^a   Lafuente Covarrubias, Omar ^a   Sánchez Sobrino, Beatriz ^a   Carballido Rodríguez, Joaquín ^a   Rodríguez Reina, Gabriel ^a   Rengifo Abadd, Diego ^a   Medina Carrizo, Amparo ^a   Sanz Moreno, Carmen ^a   Fernández Fernández, José ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Expanded criteria donor; Maastricht type III donor; Non Heart beating donor

Indexed keywords

AGED; ARTICLE; CLASSIFICATION; DONOR; FEMALE; HEART ARREST; HUMAN; KIDNEY TRANSPLANTATION; MALE; METHODOLOGY; MIDDLE AGED; PROGRAM DEVELOPMENT; TRANSPLANTATION;

AGED; FEMALE; HEART ARREST; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGRAM DEVELOPMENT; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84873709100     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2012.Jul.11539     Document Type: Article

References (13)

1. Domínguez-Gil B, Haase-Kromwijk B, Van Leiden H, Neuberger J, Coene L, Morel P, et al. Current situation of donation alter circulatory death in european countries. Transpl Int 2011;24(7):676- 86.
2. Kootstra G, Daemen JH, Oomen AP. Categories of non-heartbeatingdonors. Transplant Proc 1995;27(5):2893-4.
3. Ledicnh H, Bonvoisin C, Weekers L, de Roover A, Honoré P, Squifflet JP, et al. Results of kidney transplantation from donors after cardiac death. Transplant Proc 2010;42:2407-14.
4. Shemie SD, Baker AJ, Knoll G, Wall W, Rocker G. Donation after cardiocirculatory death in Canada. CMAJ 2006;175(8):S1-S24.
5. Documento de consenso de la ONT sobre donación en asistolia. Available at: http://www.ont.es/infesp/DocumentosDeConsenso/DONACIÓN EN ASISTOLIA EN ESPAÑA. SITUACIÓN ACTUAL Y RECOMENDACIONES.pdf. [Accessed: May 10, 2012].
6. Corral E, Maynar J, Saralegui I, Manzano A. Donantes a corazón parado tipo III de Maastricht: una opción real. Med Intensiva 2011;35:59-60.
7. Sanchez-Izquierdo A, Cisneros A, García-Guijarro R, Montejo JC, Baldrés A. Donantes tipo III de Maastricht (cartas al director). Med Intensiva 2011;35:524-5.
8. Shemie SD, Doig C, Dickens B, Byrne P, Wheelock B, Rocker G, et al. Severe brain injury to neurological determination of death: Canadian forum recommendations. CMAJ 2006;174(6):S1-12.
9. DeVita MA, Mori-Brooks M, Zawistowski C, Rudich S, Daly B, Chaitin E. Donors alter cardiac death: validation of identification criteria (DVIC) study for predictors of rapid death. Am J Transplant 2008;8:432-44.
10. Amenabar J, Arriceta G, Beneyto I, Bernis C, Calvo N, Crespo JF, et al. Estrategias de prevención y tratamiento de la enfermedad por citomegalovirus en pacientes con trasplante renal. Nefrologia Sup Ext 2012;3(1):21-7.
11. Pieter ER, Snoeijs M, van Heurn LW. DCD kidney transplantation: results and measures to improve outcome. Curr Opin Organ Transplant 2010;15:177-82.
12. ONT. Memoria de actividades 2010. Revista española de trasplantes 2011;2:1-31.
13. Sánchez-Fructuoso A, Giorgi M, Barrientos A. Kidney transplantation from non-heartbeating donors: a Spanish view. Transplantation Reviews 2007;21:249-54.